DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

Parexel International (NASDAQ: PRXL)

68.68 -0.54 (-0.78%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PRXL $68.68 -0.78%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $69.08
Previous Close $69.22
Daily Range $68.13 - $69.42
52-Week Range $52.19 - $72.69
Market Cap $3.8B
P/E Ratio 25.26
Dividend (Yield) $0.00 (0.0%)
Volume 736,206
Average Daily Volume 761,716
Current FY EPS $2.75

Sector

Healthcare

Industry

Healthcare IT

Parexel International (PRXL) Description

The Company provides a range of expertise in clinical research, medical communications services, consulting, and informatics and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Website: http://www.parexel.com/

News & Commentary Rss Feed

4 Disruptive Stocks Biotechs Depend On

Contract research organizations Quintiles (Q), Icon PLC (ICLR), Covance (CVD), and Parexel (PRXL) are redefining how biopharma discovers and develops new therapies.

After Hours Most Active for Jul 28, 2015 : TWTR, SIG, JD, PRXL, ACWI, T, ABEV, MRK, BAC, GILD, UTIW

After Hours Most Active for Jul 28, 2015 : TWTR, SIG, JD, PRXL, ACWI, T, ABEV, MRK, BAC, GILD, UTIW, FB

PAREXEL (PRXL) Expands In Model-Based Drug Development - Analyst Blog

PAREXEL International (PRXL) in Focus: Stock Slumps 7.7% - Tale of the Tape

PAREXEL Cuts FY15 & Q4 View, Initiates Restructuring Plan - Analyst Blog

Parexel International (PRXL) Highlighted As Weak On High Volume

Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates

Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates

New Lifetime High Reached By Parexel International (PRXL)

PAREXEL Up on Perceptive MyTrials DDM Solution Expansion - Analyst Blog

PAREXEL Launches Next Generation Data-Driven Monitoring Capabilities Within Perceptive MyTrials® Sol

PAREXEL Launches Next Generation Data-Driven Monitoring Capabilities Within Perceptive MyTrials® Solution

See More PRXL News...

PRXL's Top Competitors

PRXL $68.68 (-0.78%)
Current stock: PRXL
TMO $139.12 (-0.36%)
Current stock: TMO
ILMN $218.87 (0.77%)
Current stock: ILMN
WAT $132.59 (-0.59%)
Current stock: WAT